文献速递临床生化临床免疫

血清高密度脂蛋白胆固醇降低与COVID-19感染严重程度相关

Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection.
PubMed 文献 · Clin Chim Acta · 2020-07-10

该回顾性研究收集114例COVID-19患者入院首次临床实验室数据和80例健康对照,并追踪1例重症患者80天。患者总胆固醇、HDL-C和LDL-C显著低于健康对照(P < 0.001),重症组HDL-C显著低于普通组[1.01 (0.88-1.20) vs 1.21 (1.02-1.48) mmol/l, P < 0.001]。HDL-C与CRP负相关(r = -0.396, P < 0.001)、与淋巴细胞正相关(r = 0.336, P < 0.001),ROC的AUC为0.732(P < 0.001),调整OR为0.023(95% CI 0.002-0.227)。结论为血清HDL-C降低与COVID-19感染严重程度相关。

要点

  • COVID-19患者总胆固醇、HDL-C和LDL-C显著低于健康对照(P < 0.001)。
  • 重症组HDL-C显著低于普通组[1.01 (0.88-1.20) vs 1.21 (1.02-1.48) mmol/l, P < 0.001]。
  • HDL-C与CRP负相关(r = -0.396),与淋巴细胞正相关(r = 0.336)。

核心结论

  • 血清HDL-C降低与COVID-19感染严重程度相关。

研究设计与样本

  • 回顾性研究,收集114例COVID-19患者入院首次临床实验室数据和80例健康对照。
  • 追踪1例重症患者从感染早期至恢复期共80天的血清脂质谱、COVID-19核酸和胸部CT。

主要发现

  • 与健康对照相比,患者总胆固醇、HDL-C和LDL-C浓度急剧降低(P < 0.001)。
  • 重症组HDL-C浓度显著低于普通组[1.01 (0.88-1.20) vs 1.21 (1.02-1.48) mmol/l, P < 0.001]。
  • 1例重症患者血清胆固醇浓度在早期显著降低、恢复期恢复正常,HDL-C变化与核酸检测和胸部CT结果一致。
  • HDL-C与CRP负相关(r = -0.396, P < 0.001),与淋巴细胞正相关(r = 0.336, P < 0.001)。
  • HDL-C的ROC曲线AUC为0.732(P < 0.001),调整OR为0.023(95% CI 0.002-0.227)。

关键数值与推荐

  • 重症组与普通组HDL-C比较:1.01 (0.88-1.20) vs 1.21 (1.02-1.48) mmol/l,P < 0.001。
  • HDL-C与CRP相关性:r = -0.396,P < 0.001。
  • HDL-C与淋巴细胞相关性:r = 0.336,P < 0.001。
  • HDL-C的ROC曲线AUC为0.732(P < 0.001)。
  • HDL-C调整OR为0.023(95% CI 0.002-0.227)。

临床怎么用

  • 可将血清HDL-C降低作为COVID-19感染严重程度的实验室关联指标进行关注。
  • 动态监测HDL-C变化或有助于辅助观察病情演变,但需结合核酸和胸部CT等结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19 infection is epidemic worldwide. We describe the serum lipid profile of the patients with COVID-19 infection. METHODS: In this retrospective study, we collected the first clinical laboratory data of 114 patients on admission, and 80 healthy controls. Meanwhile, we monitored the serum lipid profile, COVID-19 nucleic acid and chest CT scan of a severe patient from the early stage of infection to the recovery period for a total of 80 days. RESULTS: Compared with the healthy controls, the patients had sharply decreased concentrations of total cholesterol, HDL-cholesterol and LDL-cholesterol (P < 0.001). Among the patients, HDL-cholesterol concentration in severe groups was significantly lower than the common groups [1.01 (0.88-1.20) vs 1.21 (1.02-1.48) mmol/l, P < 0.001]. The lipid profile of a severe patient showed that serum cholesterol concentration significantly decreased in the early stage and returned to be normal in the recovery period. Moreover, the change of HDL-cholesterol in this patient was consistent with the results of nucleic acid tests and chest CT scans. In correlation analysis, HDL-cholesterol concentration was negatively correlated with C-reactive protein (CRP, r = -0.396, P < 0.001) and positively correlated with lymphocytes (r = 0.336, P < 0.001). The area under curve (AUC) in receiver operating characteristic (ROC) of HDL-cholesterol was 0.732 (P < 0.001), and, the adjusted odd ratio (OR) of HDL-cholesterol was 0.023 (95% CI 0.002-0.227). CONCLUSIONS: Decreased serum HDL-cholesterol is associated with the severity of COVID-19 infection.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Hu X, Chen D, Wu L, et al. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020. PMID: 32653486. doi:10.1016/j.cca.2020.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。